NYSE$BLCO
Bausch + Lomb Corp · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Reported a strong first quarter with revenue growth across all segments.
Bausch + Lomb announced its first-quarter 2023 financial results, with revenues of $931 million, a 5% increase as reported and an 8% increase on a constant currency basis compared to the first quarter of 2022. The company's GAAP net loss attributable to Bausch + Lomb Corporation was $90 million, while adjusted EBITDA was $141 million.
- Revenues of $931 million.
- GAAP Net Loss Attributable to Bausch + Lomb Corporation of $90 Million.
- Adjusted EBITDA (non-GAAP) of $141 Million.
- Revenues Grew 5% as Reported and 8% on a Constant Currency Basis Compared to the First Quarter of 2022, Driven by Growth Across All Segments.
Headline financials
Revenue & EPS history
Bausch + Lomb · Revenue · Quarterly
$931M
Revenue by segment
Bausch + Lomb · $931M total across 3 segments · Q1 2023
- Vision Care$587M+4.8%63.1%
- Surgical$183M+5.2%19.7%
- Pharmaceuticals$161M+50.5%17.3%
Forward guidance
Bausch + Lomb provided guidance for the full year of 2023 with revenue range of $3.90 – $3.95 billion, reflecting anticipated growth of 5-6% on a constant currency basis and full-year Adjusted EBITDA range of $700 – $750 million.
Tailwinds
- Full-year revenue range of $3.90 – $3.95 billion, reflecting anticipated growth of 5-6% on a constant currency basis
- Full-year Adjusted EBITDA range of $700 – $750 million
- $760 million at the mid-point of the full-year Adj. EBITDA guidance range, adjusted for currency headwinds
- Foreign exchange revenue and Adjusted EBITDA headwinds expected to be approximately $50 million and $35 million for the full year, respectively
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2023
-1.0%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-1.0%
Avg return
30 days after
43%
9 / 21 earnings
Positive
+18.7%
Q4 2023
Best reaction
-15.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.8% | +2.9% | -1.0% | |
| Q4 2025 | +0.2% | +1.5% | -11.3% | |
| Q3 2025 | +2.1% | +0.3% | +6.5% | |
| Q1 2025 | -15.7% | -17.1% | -16.4% | |
| Q4 2024 | -0.3% | -3.3% | -4.8% | |
| Q3 2024 | -2.3% | -4.3% | -4.5% | |
| Q2 2024 | -0.1% | -8.7% | -2.6% | |
| Q1 2024 | -4.7% | -0.7% | +5.5% | |
| Q4 2023 | +18.7% | +15.7% | +10.8% | |
| Q3 2023 | +4.6% | +2.9% | -4.3% | |
| Q2 2023 | -2.5% | -3.4% | -7.2% | |
| Q1 2023 | +0.1% | +4.6% | +4.4% | |
| Q4 2020 | +0.4% | -3.7% | -14.1% | |
| Q4 2022 | +0.4% | -3.7% | -14.1% | |
| Q3 2022 | -4.9% | +5.6% | +7.9% | |
| Q3 2021 | -4.9% | +5.6% | +7.9% | |
| Q2 2022 | +4.7% | +6.3% | +1.2% | |
| Q2 2021 | +4.7% | +6.3% | +1.2% | |
| Q1 2022 | -6.8% | -14.6% | +5.0% | |
| Q4 2021 | -6.8% | -14.6% | +5.0% | |
| Q1 2021 | -6.8% | -14.6% | +5.0% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro